Latozinemab Antibody
Latozinemab (AL001) is a humanized monoclonal antibody that selectively targets and inhibits Sortilin, thereby blocking its interaction with progranulin (PGRN) . This mechanism is being investigated in preclinical research for frontotemporal dementia and Alzheimer's disease, with studies exploring its effects in both cellular and animal models.
Product Specifications
Product Name Alternative
Sortilin, AL-001, GSK-4527223, NeurotensinReceptor, Neurotensin Receptor
Target
Neurotensin Receptor
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Pharmacology & Drug Discovery
Concentration
11.37 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
146.28 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1020507-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O157:H7 Uncharacterized sufE-like protein ygdK (ygdK)
Sign In for Pricing
View Details MBS1020507-02 0.1 mg (E-Coli)
Recombinant Escherichia coli O157:H7 Uncharacterized sufE-like protein ygdK (ygdK)
Sign In for Pricing
View Details MBS1020507-03 0.02 mg (Yeast)
Recombinant Escherichia coli O157:H7 Uncharacterized sufE-like protein ygdK (ygdK)
Sign In for Pricing
View Details MBS1020507-04 0.1 mg (Yeast)
Recombinant Escherichia coli O157:H7 Uncharacterized sufE-like protein ygdK (ygdK)
Sign In for Pricing
View Details MBS1020507-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli O157:H7 Uncharacterized sufE-like protein ygdK (ygdK)
Sign In for Pricing
View Details MBS1020507-06 0.02 mg (Mammalian-Cell)
Recombinant Escherichia coli O157:H7 Uncharacterized sufE-like protein ygdK (ygdK)
Sign In for Pricing
View Details